Psilocybin Therapy May Address Mental Health Concerns
NYU Langone study shows that psilocybin therapy may improve mental health in cancer patients and patients with alcohol use disorder.
Police Seizures of Psilocybin Are Soaring Throughout U.S.
NYU Langone study finds that law-enforcement seizures of psilocybin have jumped 369 percent since 2017, suggesting drug may be easier to access.
Participate in a Psychedelic Medicine Clinical Trial | NYU Langone Health
Learn more about participating in clinical trials being conducted by NYU Langone’s Center for Psychedelic Medicine.
Hallucinogenic Drug Helps Patients with Advanced Cancer
NYU Langone study finds the hallucinogenic drug psilocybin, when combined with counseling, relieves depression and anxiety in cancer patients.
Psychedelic Drug Therapy May Help Treat Alcohol Addiction
NYU Langone study shows that 2 doses of psilocybin combined with psychotherapy reduces alcohol consumption by 83 percent among heavy drinkers.
Post-Traumatic Stress Disorder Treatment with Psychedelic Drugs | NYU Langone Health
NYU Langone’s High School Bioethics Project examines PTSD and the ethical implications of using psychedelics like psilocybin to treat symptoms.
Psychedelic Drug Benefits Persist in People with Cancer
NYU Langone study finds a psychedelic drug improved emotional distress in people with cancer for nearly five years after treatment.
Novel Therapeutic Agents for Hard-to-Treat Mental Conditions
NYU Langone’s Dr. Michael P. Bogenschutz, Dr. Stephen Ross, and colleagues explore therapeutic agents such as psilocybin, cannabidiol, and MDMA.
Center for Psychedelic Medicine Research | NYU Langone Health
At NYU Langone’s Center for Psychedelic Medicine, our researchers aim to realize the clinical potential of these drugs and maximize their safety for patients.
Center for Psychedelic Medicine in the Media | NYU Langone Health
Read articles, watch videos, and listen to podcasts featuring faculty and research from NYU Langone’s Center for Psychedelic Medicine.